glp-1 shortage The drug is over. What's next for the compounders? The promise and peril of

Often the first benefit patients notice typically within one to two weeks

10,28 This is especially concerning in patients who may have international normalized ratios (INRs) that trend higher because the deficiency of vitamin K activity will continue to elevate the INR

An RCT in 72 patients with NAFLD found that NAC (600 mg twice daily) for 3 months significantly improved liver enzymes (ALT, AST) and markers of oxidative stress compared to control, though it did not significantly improve liver histology on biopsy (Khoshbaten et al., Hepat Mon, 2010) [33]

[20]Sharma P, Dubey RS

Adoption of these agents was underwhelming, however ( ) and tirzepatide (Zepbound ), approved for the treatment of obesity in 2021 and 2024, respectively, produced corresponding mean weight loss of 17% and 23% in clinical trials of subjects with obesity, but without T2D ( It is not a coincidence that AOMs are demonstrating progressively superior effectiveness